Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus

Journal:

Journal of the American College of Cardiology

Published:

2026-04-15

DOI:

10.1016/j.jacc.2026.02.5123

Affiliations:

23

Authors:

21

Go to article

Institutions	Authors	Share
Yale University, United States of America (USA)	4.250000	0.20
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	2.500000	0.12
University of Michigan (U-M), United States of America (USA)	2.000000	0.10
Janssen Research & Development, LLC (J&J PRD), United States of America (USA)	1.000000	0.05
The University of Hong Kong (HKU), China	1.000000	0.05
Taipei Medical University (TMU), Taiwan	1.000000	0.05
University of Calgary (U of C), Canada	1.000000	0.05
The University of Edinburgh, United Kingdom (UK)	1.000000	0.05
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.05
IQVIA, United States of America (USA)	1.000000	0.05
IQVIA China, China	1.000000	0.05
Yale New Haven Hospital (YNHH), United States of America (USA)	0.750000	0.04
VA Salt Lake City Health Care System, United States of America (USA)	0.750000	0.04
Shenzhen University (SZU), China	0.500000	0.02
Laboratory of Data Discovery for Health (D24H), China	0.500000	0.02
UCL, United Kingdom (UK)	0.500000	0.02
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK)	0.500000	0.02
UCLA Health, United States of America (USA)	0.500000	0.02
University of California, Los Angeles (UCLA), United States of America (USA)	0.250000	0.01

Interested in Cardiovascular Medicine and Haematology?